PRECISESADS Sustainability at ELIXIR LU
Description
Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases
Accession number
ELU-1-A946B9-1
Project acronym
PRECISESADS
Start date
2014-02-01
End date
2019-01-31
Funding
IMI1 - Call 8 (Grant number 115565)
Types
| Accession number | Title | Create date | Study | hosted at UL |
| ELU-2-E592B0-1 | PRECISESADS: Cross Sectional Study & Inception Cohort data | 2017-01-19 | PRECISESADS: Cross Sectional Study & Inception Cohort | Yes |
| ELU-2-ECD933-1 | PRECISESADS: Cross Sectional Study Data | - | PRECISESADS: Cross Sectional Study - Lupus patients and healthy donors | Yes |
| ELU-2-C53319-1 | PRECISESADS: Mice Study Data | - | PRECISESADS: Mice Study - Spontaneous mouse models and genetic controls | Yes |
| Title | Primary purpose | Study type | Organism |
| PRECISESADS: Cross Sectional Study & Inception Cohort | Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases Mechanisms for the Improvement of Drug Development and Therapy |
|
|
| PRECISESADS: Cross Sectional Study - Lupus patients and healthy donors | Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Cross Sectional Study |
|
|
| PRECISESADS: Mice Study - Spontaneous mouse models and genetic controls | Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Mouse models |
|
|
